06Dec 2021
Validation of Four Cutaneous Squamous Cell Carcinoma Staging Systems Using Nationwide Data

Validation of Four Cutaneous Squamous Cell Carcinoma Staging Systems Using Nationwide Data

Cutaneous squamous cell carcinoma (cSCC) is the second most common cancer worldwide with relatively low metastatic potential (2‐5%). Developments in therapeutic options have highlighted the need to better identify high‐risk patients who could benefit from closer surveillance, adjuvant therapies, and baseline/follow‐up imaging, while at the same time safely omitting low‐risk patients from further follow‐up. Controversy remains regarding the predictive performance of current cSCC staging systems and which methodology to adopt...

  • #dermatology

Like

Save

Share